Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00781300Phase 4Completed
Phase 4, randomised trial of loteprednol etabonate in pterygium (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Intraocular Pressure at 6 weeks. Started Mar 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00781300.